lercea glp-1 RACGP Counterfeit weight loss products claiming

This restriction was implemented following concerns about diet medications in the late 1990s, including the fen-phen scandal

Higher dose data is absent

In comparison, Keytruda became the best-selling drug nine years after it was first approved

Long-Term Economic Impact GLP-1-RAs have long-term economic implications, beyond drug expenses and healthcare savings

A new study found that the cost of GLP-1 drugs like Wegovy and Zepbound is too high to justify their benefits Researchers analyzed national survey data to assess the long-term impact of four anti-obesity medications, including tirzepatide and semaglutide the active ingredients in Zepbound and Wegovy, respectively